Fliar explore / investors

Biopharmaceuticals investors worldwide.

There are 100 investor pages for Biopharmaceuticals in the Fliar directory. That is 97 investor lists and 3 angel lists. The list with the most capital behind it is Biopharmaceuticals investors in Cambridge ($218.4B across the rounds it covers).

In this directory100investor pages
117 locations

100 pages

Investor listBiopharmaceuticals investors in CambridgeBiopharmaceuticals · Cambridge, United States904 investors307 companies$218.4B in roundsInvestor listBiopharmaceuticals investors in San FranciscoBiopharmaceuticals · San Francisco, United States785 investors208 companies$133.9B in roundsInvestor listBiopharmaceuticals investors in San DiegoBiopharmaceuticals · San Diego, United States680 investors215 companies$122.9B in roundsInvestor listBiopharmaceuticals investors in BostonBiopharmaceuticals · Boston, United States416 investors109 companies$76B in roundsInvestor listBiopharmaceuticals investors in SeattleBiopharmaceuticals · Seattle, United States276 investors56 companies$41.3B in roundsInvestor listBiopharmaceuticals investors in ShanghaiBiopharmaceuticals · Shanghai, China313 investors67 companies$41B in roundsInvestor listBiopharmaceuticals investors in WalthamBiopharmaceuticals · Waltham, United States219 investors34 companies$40.5B in roundsInvestor listBiopharmaceuticals investors in New York CityBiopharmaceuticals · New York City, United States313 investors103 companies$37.9B in roundsInvestor listBiopharmaceuticals investors in SuzhouBiopharmaceuticals · Suzhou, China176 investors31 companies$34.6B in roundsInvestor listBiopharmaceuticals investors in LondonBiopharmaceuticals · London, United Kingdom278 investors70 companies$33.7B in roundsInvestor listBiopharmaceuticals investors in Redwood CityBiopharmaceuticals · Redwood City, United States153 investors27 companies$23.6B in roundsInvestor listBiopharmaceuticals investors in Menlo ParkBiopharmaceuticals · Menlo Park, United States200 investors29 companies$22.7B in roundsInvestor listBiopharmaceuticals investors in WatertownBiopharmaceuticals · Watertown, United States127 investors22 companies$21.9B in roundsInvestor listBiopharmaceuticals investors in PhiladelphiaBiopharmaceuticals · Philadelphia, United States182 investors39 companies$18.9B in roundsInvestor listBiopharmaceuticals investors in BaselBiopharmaceuticals · Basel, Switzerland126 investors39 companies$17.1B in roundsInvestor listBiopharmaceuticals investors in MunichBiopharmaceuticals · Munich, Germany90 investors15 companies$15.7B in roundsInvestor listBiopharmaceuticals investors in San MateoBiopharmaceuticals · San Mateo, United States117 investors19 companies$15.5B in roundsInvestor listBiopharmaceuticals investors in DurhamBiopharmaceuticals · Durham, United States138 investors30 companies$14.3B in roundsInvestor listBiopharmaceuticals investors in BoulderBiopharmaceuticals · Boulder, United States113 investors11 companies$12.4B in roundsInvestor listBiopharmaceuticals investors in Palo AltoBiopharmaceuticals · Palo Alto, United States129 investors29 companies$12.1B in roundsInvestor listBiopharmaceuticals investors in PudongBiopharmaceuticals · Pudong, China143 investors19 companies$12B in roundsInvestor listBiopharmaceuticals investors in BerkeleyBiopharmaceuticals · Berkeley, United States130 investors21 companies$11.6B in roundsInvestor listBiopharmaceuticals investors in LexingtonBiopharmaceuticals · Lexington, United States152 investors26 companies$11.4B in roundsInvestor listBiopharmaceuticals investors in CopenhagenBiopharmaceuticals · Copenhagen, Denmark107 investors33 companies$10.9B in roundsInvestor listBiopharmaceuticals investors in ParisBiopharmaceuticals · Paris, France163 investors43 companies$10.6B in roundsInvestor listBiopharmaceuticals investors in Los AngelesBiopharmaceuticals · Los Angeles, United States72 investors21 companies$10.4B in roundsInvestor listBiopharmaceuticals investors in San CarlosBiopharmaceuticals · San Carlos, United States125 investors22 companies$8.5B in roundsInvestor listBiopharmaceuticals investors in NewtonBiopharmaceuticals · Newton, United States57 investors10 companies$8.4B in roundsInvestor listBiopharmaceuticals investors in OxfordBiopharmaceuticals · Oxford, United Kingdom123 investors27 companies$8B in roundsInvestor listBiopharmaceuticals investors in VancouverBiopharmaceuticals · Vancouver, Canada120 investors33 companies$7.7B in roundsInvestor listBiopharmaceuticals investors in EmeryvilleBiopharmaceuticals · Emeryville, United States80 investors10 companies$7.6B in roundsInvestor listBiopharmaceuticals investors in DublinBiopharmaceuticals · Dublin, Ireland84 investors17 companies$7.3B in roundsInvestor listBiopharmaceuticals investors in MontrealBiopharmaceuticals · Montreal, Canada93 investors32 companies$6.9B in roundsInvestor listBiopharmaceuticals investors in RockvilleBiopharmaceuticals · Rockville, United States95 investors20 companies$6.8B in roundsInvestor listBiopharmaceuticals investors in BeijingBiopharmaceuticals · Beijing, China102 investors22 companies$6.7B in roundsInvestor listBiopharmaceuticals investors in BrisbaneBiopharmaceuticals · Brisbane, Australia92 investors16 companies$5.9B in roundsInvestor listBiopharmaceuticals investors in New HavenBiopharmaceuticals · New Haven, United States82 investors19 companies$5.7B in roundsInvestor listBiopharmaceuticals investors in GaithersburgBiopharmaceuticals · Gaithersburg, United States82 investors18 companies$5.3B in roundsInvestor listBiopharmaceuticals investors in Mountain ViewBiopharmaceuticals · Mountain View, United States63 investors10 companies$5.2B in roundsInvestor listBiopharmaceuticals investors in SingaporeBiopharmaceuticals · Singapore, Singapore94 investors22 companies$5.2B in roundsInvestor listBiopharmaceuticals investors in LeidenBiopharmaceuticals · Leiden, Netherlands67 investors19 companies$5B in roundsInvestor listBiopharmaceuticals investors in MalvernBiopharmaceuticals · Malvern, United States90 investors17 companies$5B in roundsInvestor listBiopharmaceuticals investors in HangzhouBiopharmaceuticals · Hangzhou, China101 investors31 companies$4.9B in roundsInvestor listBiopharmaceuticals investors in DallasBiopharmaceuticals · Dallas, United States54 investors10 companies$4.9B in roundsInvestor listBiopharmaceuticals investors in ChengduBiopharmaceuticals · Chengdu, China51 investors10 companies$4.7B in roundsInvestor listBiopharmaceuticals investors in IrvineBiopharmaceuticals · Irvine, United States63 investors16 companies$4.6B in roundsInvestor listBiopharmaceuticals investors in HaywardBiopharmaceuticals · Hayward, United States64 investors10 companies$4.5B in roundsInvestor listBiopharmaceuticals investors in SchlierenBiopharmaceuticals · Schlieren, Switzerland64 investors11 companies$3.9B in rounds
About this directory page

Biopharmaceuticals investors

There are 100 investor pages for Biopharmaceuticals in the Fliar directory. That is 97 investor lists and 3 angel lists. The list with the most capital behind it is Biopharmaceuticals investors in Cambridge ($218.4B across the rounds it covers).

They are concentrated in United States (47), China (10), United Kingdom (5), Switzerland (5) and Canada (3). In all, Biopharmaceuticals investor pages span 117 locations.

Close neighbours of Biopharmaceuticals are Life Sciences, Oncology, HealthTech, Artificial Intelligence, Medical Devices and Cybersecurity.

Keep browsing across Fliar: Biopharmaceuticals company lists (1).

Same market, other page types
All sectors A–Z 838
All locations for Biopharmaceuticals A–Z 117